NLRP3 and metabolic disease: The NLRP3 inflammasome, activated via ROS accumulation, exhibited elevated ASC levels and arrhythmic expression in the SD + SiNPs-treated ELGs, mirroring findings in neurodegenerative and metabolic disorders [66, 67].